Fresenius Medical Care AG & Co. (FMS)
(Delayed Data from NYSE)
$20.75 USD
-0.39 (-1.84%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $20.75 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Price, Consensus and EPS Surprise
FMS 20.75 -0.39(-1.84%)
Will FMS be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for FMS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for FMS
FMS Stock Rides on Diversified Portfolio and Restructuring Initiatives
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now
FMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Why Fresenius (FMS) is a Top Momentum Stock for the Long-Term
Other News for FMS
Focus Graphite Expands Private Placement and Updates Incentive Plan
Focus Graphite Increases Offering on Non-Brokered Private Placement & Approval of Amended Equity Incentive Plan
Focus Graphite Sets Private Placement to Boost Capital
Focus Graphite Announces Non-Brokered Private Placement
Fresenius Medical Care AG & Co. KGaA (0H9X) Gets a Sell from Jefferies